PCA and multimodal analgesia
Why examiners ask this
Postoperative pain is in nearly every post-op section, and the examiner wants a plan, not a list of drugs. The topic tests application of knowledge about PCA settings and multimodal agents, judgment about who should not have a basal infusion, and adaptability when the patient on a PCA is found somnolent with a respiratory rate of 6. It is also a vehicle for questions on opioid tolerance, sleep apnea and safety monitoring.
The 60-second answer
I build the plan from the bottom up. Regularly scheduled acetaminophen and an NSAID if there is no renal, bleeding or cardiac contraindication, plus a regional technique when one fits the surgery. I add dexamethasone, ketamine, lidocaine infusion or gabapentinoids selectively, based on the patient and procedure. For opioids, I use a PCA when the patient cannot yet take oral medication or needs rapid titration: hydromorphone 0.2 mg or morphine 1 mg demand dose, a 6–10 minute lockout, no basal infusion in an opioid-naive patient, and a 4-hour limit. I order sedation scoring, continuous pulse oximetry or capnography for high-risk patients, and naloxone. I transition to oral opioids as soon as the patient tolerates intake.
Decision points and the "why"
- No basal infusion in the opioid-naive — the safety of PCA rests on the patient falling asleep before they press again; a basal rate breaks that loop and increases respiratory depression without improving analgesia.
- Basal infusion in the opioid-tolerant — I replace the home opioid as a basal rate or continue it orally, because withdrawal and under-treatment are the bigger risks.
- Nobody else presses the button — PCA by proxy defeats the safety mechanism; I educate families and nurses.
- Ketamine for opioid sparing — 0.5 mg/kg at induction and 0.1–0.25 mg/kg/h reduces opioid consumption, particularly in tolerant patients and spine surgery.
- Lidocaine infusion — 1.5 mg/kg bolus and 1–2 mg/kg/h helps after open abdominal surgery and return of bowel function; I do not combine it with a peripheral nerve or fascial plane block because of LAST risk.
- Gabapentinoids selectively — they add sedation and respiratory depression with opioids, especially in the elderly, so I do not use them routinely.
- Monitoring — sedation precedes respiratory depression; I use the Pasero Opioid-induced Sedation Scale and continuous monitoring in sleep apnea and the elderly.
The complication they will inject
The nurse finds a 70-year-old with obstructive sleep apnea, on hydromorphone PCA after a hip replacement, difficult to rouse with a respiratory rate of 6 and SpO2 84%. I tell her to stimulate the patient, give oxygen, support the airway, stop the PCA and call a rapid response. I give naloxone 40 mcg IV every 2 minutes, titrated to breathing rather than full reversal, to avoid acute pain and pulmonary edema. Because naloxone is shorter-acting than hydromorphone, I start an infusion if needed and move the patient to a monitored bed. I check for contributing factors: the basal rate, renal impairment, benzodiazepines or gabapentin, and CPAP not applied. I then restart analgesia with multimodal agents and a lower opioid dose.
Pitfalls that cost points
- Listing drugs without a plan or dosing order.
- Starting a basal infusion for an opioid-naive patient.
- Giving naloxone 0.4 mg as a bolus to an opioid-tolerant patient.
- Forgetting sleep apnea and renal function when choosing the opioid and monitoring.
- Using NSAIDs without considering renal function, bleeding and anastomotic risk.
Rapid-why
Q: Why avoid morphine in renal failure? A: Morphine-6-glucuronide accumulates and causes prolonged sedation and respiratory depression; hydromorphone or fentanyl is preferable.
Q: Why is sedation a better early warning than respiratory rate? A: Sedation increases before respiratory depression and is detected at the bedside, giving time to intervene.
Q: Why does a lockout of 6–10 minutes make sense? A: It allows the peak effect of each dose before the next can be given.
Q: Why is multimodal analgesia better than more opioid? A: Drugs acting on different pathways are additive, while opioid side effects such as nausea, ileus, sedation and respiratory depression are dose-related.
Numbers to know
| Item | Value |
|---|---|
| Hydromorphone PCA | 0.2 mg demand, 6–10 min lockout |
| Morphine PCA | 1 mg demand, 6–10 min lockout |
| Naloxone titration | 40 mcg IV every 2 min |
| Ketamine | 0.5 mg/kg bolus; 0.1–0.25 mg/kg/h |
| Lidocaine infusion | 1.5 mg/kg bolus; 1–2 mg/kg/h |
| Acetaminophen | 1 g every 6 h; max 4 g/day |
Links
- Acute pain in the opioid-tolerant patient (coming), Opioids and postoperative respiratory depression, Obstructive sleep apnea (coming), TAP, ESP, PECS, QL and fascia iliaca blocks (coming), Dexmedetomidine and ketamine (coming)
- ASA Practice Guidelines for Acute Pain Management in the Perioperative Setting; ASRA/AAPM/ASA consensus guidelines on intravenous ketamine for acute pain
Sources
Sources have not been attached to this page yet.